motixafortide sold brand name aphexda medication used treatment multiple motixafortide hematopoietic stem cell mobilizer given subcutaneous motixafortide approved medical use united states september motixafortide indicated combination filgrastim granulocytecolony stimulating factor gcsf mobilize hematopoietic stem cells peripheral blood collection subsequent autologous transplantation people multiple motixafortide international nonproprietary pharmacologyrelated article stub help wikipedia expanding ithttpsenwikipediaorgwikimotixafortide